Kaiser v. Cigna Corp.
Opinion of the Court
TRANSFER ORDER
On December 16, 2002, the Panel ordered the parties in this litigation to show cause why this action (.Kaiser) should not be transferred, under 28 U.S.C. § 1407, to the Southern District of Florida for inclusion in MDL-1334 pretrial proceedings already in progress there before Judge Federico A. Moreno as the transferee judge. The Kaiser plaintiffs and defendant Cigna Corp. (Cigna) oppose inclusion of Kaiser in MDL-1334 on the grounds that i) Kaiser has been extensively litigated in Illinois state court and further pretrial proceedings in the action are not necessary; ii) a nationwide class settlement has been reached in Kaiser, and iii) the Illinois federal court (Chief Judge G. Patrick Murphy) can expeditiously review this settlement. The MDL-1334 provider plaintiffs favor inclusion of Kaiser in MDL-1334 on the grounds that i) Judge Moreno has certified a class that overlaps the class defined in Kaiser; ii) the class settlement in Kaiser, whether approved or not approved, may have collateral consequences affecting the management of the litigation as a whole in MDL-1334; iii) settlement proceedings, in general, have been deemed appropriate for inclusion by the Panel in Section 1407 pretrial proceedings; and iv) the MDL-1334 transferee judge is in the best position to consider the settlement and any other issues presented by Kaiser in the overall context of the litigation comprising MDL-1334. The Panel agrees that the action should be transferred into MDL-1334.
Thus, on the basis of the papers filed and hearing session held, the Panel finds that Kaiser involves common questions of fact with the actions in this litigation previously centralized in the Southern District of Florida. Transfer of this action to the Southern District of Florida for inclusion in the coordinated or consolidated pretrial proceedings occurring in that district will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. The Panel further finds that transfer of Kaiser is appropriate for the reasons expressed by the Panel in its previous orders directing centralization in this docket. The Panel held that the Southern District of Florida was the proper Section 1407 forum for actions concerning the managed care defendants’ alleged liability for their cost-containment policies. See In re Man
It is established Panel and court of appeals precedent that settlement matters are appropriate pretrial proceedings subject to centralization under § 1407. In re Patenaude, 210 F.3d 135, 142-144 (3d Cir. 2000).
Inclusion of Kaiser in MDL-1334 will not adversely impact consideration of the Kaiser settlement. Judge Moreno has already invited Cigna to present the proposed settlement to him and he has stated that he has no predisposition about the fairness and adequacy of this settlement.
IT IS THEREFORE ORDERED that, pursuant to 28 U.S.C. § 1407, Timothy N. Kaiser, M.D., et al., v. Cigna Corp., et al., S.D. Illinois, C.A. No. 3:02-1179, is transferred to the Southern District of Florida and, with the consent of that court, assigned to the Honorable Federico A. Moreno for inclusion in the coordinated or consolidated pretrial proceedings occurring there.
.See also In re Lease Oil Antitrust Litigation (No. II), 48 F.Supp.2d 699 (S.D.Tex. 1998) (noting that the Panel included an action in Section 1407 proceedings in which a global settlement had been filed in one of the trans-feror courts); In re Viatron Computer Systems Corp. Securities Litigation, 462 F.Supp. 382 (J.P.M.L. 1978) (upon order to show cause, the Panel transferred a tag-along action that was near partial settlement); In re Armored Car Antitrust Litigation, 462 F.Supp. 394 (J.P.M.L. 1978) (the Panel included an action in a mul-tidistrict docket even though the MDL litigation had already been preliminarily settled).
. 2000 U.S. Dist. LEXIS 5101 (J.P.M.L. Apr. 14, 2000).
. Partial settlements in multidistrict litigation involving multiple defendants are routine. See, e.g., MDL-1203-In re Diet Drugs (Phentermine, Fenfluramine, Dexfenfluramine) Products Liability Litigation (E.D.Pa. Aug. 28,
Case-law data current through December 31, 2025. Source: CourtListener bulk data.